Researchers have discovered a new chemical reaction that spontaneously makes and breaks a sulphur-sulphur bond at room temperature, offering potential applications in drug development, protein science, biotechnology, and chemical and material science.
A new research collaboration between India and Sweden is using artificial intelligence to accelerate the discovery of peptide-based therapeutics for pneumonia, aiming to shorten drug development timelines and combat drug-resistant infections.
The process of discovering and developing a new drug can take decades and costs hundreds of millions or even billions of dollars. However, technological advances like artificial intelligence can help speed up and transform the time-consuming and labor-intensive exercise. In India, Peptris Technologies, a Bangalore-based AI drug discovery company, has announced $1 million in pre-seed round investment led by Speciale Invest.
Researchers at IIT Bombay have developed a DNA-based strategy to make drug-resistant bacteria responsive to antibiotics again, addressing the growing crisis of antimicrobial resistance.
Pharma majors are collaborating with foreign companies to develop newer drugs.
Dr Reddy's Laboratories hopes to become a true drug discovery company in the near future, said chairman K Anji Reddy and chief executive officer GV Prasad at the 24th annual general body meeting in Hyderabad on Tuesday.
Right from tractors to water pumps to environment-friendly technology to the leather industry, we develop everything. CSIR helps the Indian pharma industry develop low-cost drugs has been remarkable, says Samir K Brahmachari.
Ajay Kela, CEO of Wadhwani Foundation, highlights India's significant opportunity to lead in the diffusion of technology, creating national-scale use cases that reach millions of end-users. He also discusses the role of deep-tech startups and SMEs in job creation and the importance of upskilling initiatives.
The company is demerging its new chemical entity research unit into a separate company to meet the demands of increased spend on research and development, and to insulate investors from the risks involved. According to the deal signed with Merck, NPIL will discover and develop new drugs for two selected targets provided by Merck in the area of cancer.
Police in Ratlam, Madhya Pradesh, have uncovered a mephedrone factory operating under the guise of a poultry farm, arresting four individuals and seizing a significant quantity of the drug.
NVIDIA CEO Jensen Huang argues that Artificial Intelligence is driving the largest infrastructure buildout in human history, requiring trillions of dollars in investment and creating significant demand for skilled blue-collar labour.
Customs officials at Pune International Airport seized a large consignment of hydroponic marijuana, valued at Rs 26.8 crore, that was concealed within boxes labelled as 'Mandarin orange sacs' arriving from Bangkok.
Authorities in Chhattisgarh have uncovered illegal opium cultivation, leading to seizures and political accusations. The discovery follows a previous incident involving a BJP leader, raising questions about the state government's role.
Police in Jaipur arrested a man after discovering 363 opium plants illegally cultivated in his field, concealed among an onion crop.
A retired Navy officer has been arrested in Kerala after excise officials seized ganja and cannabis plants from his residence.
A retired Navy officer has been arrested in Kerala after excise officials seized ganja and cannabis plants from his residence.
'We could well be in a world where AI already has these dangerous capabilities and that is why there is a need for careful scientific evaluation to determine the risk and capabilities of these machines.'
Chhattisgarh Chief Minister Vishnu Deo Sai has ordered strict action against illegal opium farming after several cases surfaced in the state. The government has instructed departments to investigate and ensure stringent action against those involved.
Increasing band of expats is driving the Jubilant Organosys drug development and discovery business. Of the total 1,025 scientific manpower strength
Delhi-based pharma major Mankind Pharma on Wednesday announced a collaboration with OpenAI to institutionalise artificial intelligence (AI) across its value chain, making it one of the first few Indian pharmaceutical companies to fully integrate advanced AI into its core operations.
Only a couple of specialty wire services in the US picked up this news; the mainstream press ignored what appears to be a marked -- and dramatic shift -- in the approach to drug discovery. What we are seeing is the first big bang contribution to open source drug discovery, an initiative to rope in researchers, universities and companies to make drug breakthroughs less expensive and time-consuming.
To prevent the race for superintelligence from going off the rails, OpenAI recommends shared standards and insights from frontier labs, public oversight and accountability proportional to capabilities, building an AI-resilient ecosystem, and reporting and measurement by labs and governments on AI's impact.
Mumbai-based pharma major Wockhardt, which is gearing up to launch its promising antibiotic candidate Zaynich soon, on Friday announced a shift in its United States (US) operations. The Indian pharma giant revealed that it has decided to exit the generics pharmaceutical segment in the country.
R&D is increasingly becoming an area of focus for Indian pharma companies and most of the big companies are spending about 6%-7% of their revenues on R&D activity.
India's largest IT services company TCS believes that generative artificial intelligence (AI) is not just another tech cycle but a "civilisational shift" which will positively benefit every industry.
Researchers said compounds that are already along the pipeline to drug discovery are preferred, as they can be further tested as antivirals at an accelerated rate compared to new drug leads that would have to go through this process from scratch.
In a double-dose bid to boost growth and employment prospects, the Union Cabinet on Tuesday approved a Rs 2.07 trillion outlay for a research development and innovation (RDI) Scheme to fund private sector innovations, and an employment-linked incentive (ELI) to create over 35 million new jobs over the next two years.
New drug discovery and contract research have taken a back seat as global drug majors have slowed down their research and development offshoring to India.
Kenya's anti-doping agency says an Indian national was caught with "an illegal consignment of assorted performance enhancing substances" during a recent raid on prohibited drugs, conducted in collaboration with the country's Directorate of Criminal Investigations (DCI).
The Economic Survey on Monday said the advent of Artificial Intelligence (AI) casts a "huge pall of uncertainty" with regard to impact on workers across all skill levels. The Economic Survey 2023-24 tabled in Parliament predicted that the new-age technology, while turbocharging productivity, has the potential to disrupt employment in certain sectors. The Survey described AI as "phenomenal in its rapid pace of innovation and ease of diffusion" but also cautioned that the the future of work will be reshaped by it.
Ahmedabad-based Zydus Lifesciences said on Tuesday that a new drug application for its oral drug Desidustat used in treating anaemia in chronic kidney disease (CKD) patients had been accepted by the National Medical Products Administration of China (NMPA). In 2020, CMS International Development and Management Ltd, a wholly-owned subsidiary of China Medical System Holdings Ltd obtained an exclusive license for the product from Zydus. CKD involves a gradual loss of functioning of kidneys and eventually leads to kidney failure.
Daiichi Sankyo, Japan's third-largest drug maker, has transferred six of its early drug discovery programmes in inflammatory and infectious diseases from its Japanese research & development (R&D) facilities to India.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances